Effects of statins on clinical outcomes in hospitalized patients with COVID-19

Affiliations

¹ Investigative Pathology Laboratory, Hospital University, Federal University of Sergipe. Rua Cláudio Batista, s/n. Sanatório, Aracaju, SE, CEP 49060-100, Brazil; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil. Electronic address: prmartinsfh@gmail.com.
² Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil; Department of Internal Medicine, Federal University of Sergipe, Aracaju, SE, Brazil; Division of Cardiology, University Hospital, Federal University of Sergipe, Aracaju, SE, Brazil; São Lucas Clinic and Hospital / Rede D`Or São Luiz, Aracaju, SE, Brazil.

Paulo Ricardo Martins-Filho et al. Eur J Intern Med. 2022 Oct.

. 2022 Oct:104:113-115.

doi: 10.1016/j.ejim.2022.06.007. Epub 2022 Jun 9.

¹ Investigative Pathology Laboratory, Hospital University, Federal University of Sergipe. Rua Cláudio Batista, s/n. Sanatório, Aracaju, SE, CEP 49060-100, Brazil; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil. Electronic address: prmartinsfh@gmail.com.
² Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil; Department of Internal Medicine, Federal University of Sergipe, Aracaju, SE, Brazil; Division of Cardiology, University Hospital, Federal University of Sergipe, Aracaju, SE, Brazil; São Lucas Clinic and Hospital / Rede D`Or São Luiz, Aracaju, SE, Brazil.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors declare they have no conflicts of interest.

1. Diaz-Arocutipa C., Melgar-Talavera B., Alvarado-Yarasca Á., Saravia-Bartra M.M., Cazorla P., Belzusarri I., et al. Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients. Int J Infect Dis. 2021;110:374–381. doi: 10.1016/j.ijid.2021.08.004. - DOI - PMC - PubMed
1. Ghafoori M., Saadati H., Taghavi M., Azimian A., Alesheikh P., Mohajerzadeh M.S., et al. Survival of the hospitalized patients with COVID-19 receiving atorvastatin: a randomized clinical trial. J Med Virol. 2022 doi: 10.1002/jmv.27710. - DOI - PMC - PubMed
1. I.S. Investigators Atorvastatin versus placebo in patients with COVID-19 in intensive care: randomized controlled trial. BMJ. 2022;376 doi: 10.1136/bmj-2021-068407. - DOI - PMC - PubMed
1. Davoodi L., Jafarpour H., Oladi Z., Zakariaei Z., Tabarestani M., Ahmadi B.M., et al. Atorvastatin therapy in COVID-19 adult inpatients: a double-blind, randomized controlled trial. IJC Hear Vasc. 2021;36 doi: 10.1016/j.ijcha.2021.100875. - DOI - PMC - PubMed
1. Matli K., Al Kotob A., Jamaleddine W., Osta S.A., Salameh P., Tabbikha R., et al. Managing endothelial dysfunction in COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial at the Lebanese American University Medical Center - Rizk hospital (MEDIC-LAUMCRH). medRxiv 2022.02.02.22270341. doi:10.1101/2022.02.02.22270341. - PubMed